DataRiver offers its expertise in the development of clinical studies on medical devices of class I, IIa, IIb and III. Following the coming into force of the new regulation on medical devices (EU) 2017/745 on 25 May 2017, clinical studies will be essential in the development and life-cycle of medical devices, for obtaining and/or maintaining the CE brand. The experience gained in this field makes DataRiver a reliable partner to turn to.